CN104840934A - Traditional Chinese medicine composition for preventing and treating piglet diarrhea and preparation method of traditional Chinese medicine composition - Google Patents
Traditional Chinese medicine composition for preventing and treating piglet diarrhea and preparation method of traditional Chinese medicine composition Download PDFInfo
- Publication number
- CN104840934A CN104840934A CN201510317143.XA CN201510317143A CN104840934A CN 104840934 A CN104840934 A CN 104840934A CN 201510317143 A CN201510317143 A CN 201510317143A CN 104840934 A CN104840934 A CN 104840934A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- medicine composition
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010012735 Diarrhoea Diseases 0.000 title claims abstract description 40
- 239000003814 drug Substances 0.000 title claims abstract description 29
- 239000000203 mixture Substances 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 241000206469 Pulsatilla Species 0.000 claims abstract description 17
- 239000009806 pulsatillae Substances 0.000 claims abstract description 10
- 238000001035 drying Methods 0.000 claims abstract description 8
- 238000000605 extraction Methods 0.000 claims abstract description 3
- 239000004615 ingredient Substances 0.000 claims abstract description 3
- 239000000843 powder Substances 0.000 claims description 23
- 229930006000 Sucrose Natural products 0.000 claims description 12
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 241000756943 Codonopsis Species 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 6
- 230000002265 prevention Effects 0.000 claims description 4
- 229960004793 sucrose Drugs 0.000 claims 2
- 239000012467 final product Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 40
- 241000092665 Atractylodes macrocephala Species 0.000 abstract description 12
- 241000972672 Phellodendron Species 0.000 abstract description 11
- 208000001848 dysentery Diseases 0.000 abstract description 10
- 230000006870 function Effects 0.000 abstract description 9
- 210000002784 stomach Anatomy 0.000 abstract description 9
- 235000006886 Zingiber officinale Nutrition 0.000 abstract description 8
- 235000008397 ginger Nutrition 0.000 abstract description 8
- 241000675108 Citrus tangerina Species 0.000 abstract description 7
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract description 7
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 7
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract description 7
- 229940010454 licorice Drugs 0.000 abstract description 7
- 241000007126 Codonopsis pilosula Species 0.000 abstract description 6
- 244000273928 Zingiber officinale Species 0.000 abstract description 5
- 239000003640 drug residue Substances 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 2
- 210000000936 intestine Anatomy 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 238000011084 recovery Methods 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 239000000273 veterinary drug Substances 0.000 abstract description 2
- 238000010792 warming Methods 0.000 abstract description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 239000000284 extract Substances 0.000 description 17
- 241000132012 Atractylodes Species 0.000 description 15
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 11
- 230000007812 deficiency Effects 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 10
- 239000005720 sucrose Substances 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 239000008194 pharmaceutical composition Substances 0.000 description 7
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- FBMORZZOJSDNRQ-GLQYFDAESA-N Atractylenolide III Chemical compound C=C([C@@H]1C2)CCC[C@]1(C)C[C@@]1(O)C2=C(C)C(=O)O1 FBMORZZOJSDNRQ-GLQYFDAESA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 235000006484 Paeonia officinalis Nutrition 0.000 description 5
- 229930182470 glycoside Natural products 0.000 description 5
- 150000002338 glycosides Chemical class 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 244000025254 Cannabis sativa Species 0.000 description 4
- 244000303040 Glycyrrhiza glabra Species 0.000 description 4
- 241000736199 Paeonia Species 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000004596 appetite loss Effects 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000007654 immersion Methods 0.000 description 4
- 230000028993 immune response Effects 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 235000021266 loss of appetite Nutrition 0.000 description 4
- 208000019017 loss of appetite Diseases 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 241000208340 Araliaceae Species 0.000 description 3
- OQYBLUDOOFOBPO-UHFFFAOYSA-N Asterolide Natural products C1C2C(=C)CCCC2(C)CC2C1=C(C)C(=O)O2 OQYBLUDOOFOBPO-UHFFFAOYSA-N 0.000 description 3
- SPFYMRJSYKOXGV-UHFFFAOYSA-N Baytril Chemical compound C1CN(CC)CCN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1CC1 SPFYMRJSYKOXGV-UHFFFAOYSA-N 0.000 description 3
- FBMORZZOJSDNRQ-UHFFFAOYSA-N Demethoxy,B,HCl-Adriamycin Natural products C1C2C(=C)CCCC2(C)CC2(O)C1=C(C)C(=O)O2 FBMORZZOJSDNRQ-UHFFFAOYSA-N 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 241000972673 Phellodendron amurense Species 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 241000234314 Zingiber Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- OAXKIRPCKWQWOQ-UHFFFAOYSA-N atractylenolide III Natural products CC1=C2CC3C(CCCC3=C)CC2(O)OC1=O OAXKIRPCKWQWOQ-UHFFFAOYSA-N 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000003759 clinical diagnosis Methods 0.000 description 3
- 206010009887 colitis Diseases 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000001784 detoxification Methods 0.000 description 3
- 229960000740 enrofloxacin Drugs 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000003771 laboratory diagnosis Methods 0.000 description 3
- 150000002596 lactones Chemical group 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 208000013220 shortness of breath Diseases 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 2
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 2
- OQYBLUDOOFOBPO-KCQAQPDRSA-N Atractylenolide II Chemical compound C=C([C@@H]1C2)CCC[C@]1(C)C[C@H]1C2=C(C)C(=O)O1 OQYBLUDOOFOBPO-KCQAQPDRSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000202807 Glycyrrhiza Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241001106477 Paeoniaceae Species 0.000 description 2
- 241001079007 Phellodendron chinense Species 0.000 description 2
- 241000123887 Pulsatilla chinensis Species 0.000 description 2
- 241000702670 Rotavirus Species 0.000 description 2
- 206010067470 Rotavirus infection Diseases 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000002790 anti-mutagenic effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- OQYBLUDOOFOBPO-YDHLFZDLSA-N atractylenolide II Natural products CC1=C2C[C@H]3C(=C)CCC[C@@]3(C)C[C@@H]2OC1=O OQYBLUDOOFOBPO-YDHLFZDLSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- -1 hydroxypaeoniflorin Chemical compound 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 229930003658 monoterpene Natural products 0.000 description 2
- 150000002773 monoterpene derivatives Chemical class 0.000 description 2
- 235000002577 monoterpenes Nutrition 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 229940127249 oral antibiotic Drugs 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 210000003024 peritoneal macrophage Anatomy 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000003307 slaughter Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- ZTVSGQPHMUYCRS-SWLSCSKDSA-N (4as,8as)-3,8a-dimethyl-5-methylidene-4a,6,7,8-tetrahydro-4h-benzo[f][1]benzofuran-2-one Chemical compound C=C([C@@H]1C2)CCC[C@]1(C)C=C1C2=C(C)C(=O)O1 ZTVSGQPHMUYCRS-SWLSCSKDSA-N 0.000 description 1
- FMNQRUKVXAQEAZ-JNRFBPFXSA-N (5z,8s,9r,10e,12s)-9,12-dihydroxy-8-[(1s)-1-hydroxy-3-oxopropyl]heptadeca-5,10-dienoic acid Chemical compound CCCCC[C@H](O)\C=C\[C@@H](O)[C@H]([C@@H](O)CC=O)C\C=C/CCCC(O)=O FMNQRUKVXAQEAZ-JNRFBPFXSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- LATYEZNGPQKAIK-UHFFFAOYSA-N 6'-O-benzoylpaeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(COC(=O)C=6C=CC=CC=6)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 LATYEZNGPQKAIK-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241001083548 Anemone Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- LATYEZNGPQKAIK-HRCYFWENSA-N Benzoylpaeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](COC(=O)C=2C=CC=CC=2)O1)O)C)OC(=O)C1=CC=CC=C1 LATYEZNGPQKAIK-HRCYFWENSA-N 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010007688 Carotid artery thrombosis Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 241001660788 Cinchona calisaya Species 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 244000247747 Coptis groenlandica Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000224432 Entamoeba histolytica Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- KLFIUQCKSSAFFU-QHOIGUMUSA-N Galloylpaeoniflorin Natural products O=C(OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@]23[C@]4(COC(=O)c5ccccc5)[C@@H]5O[C@@]2(C)C[C@@](O)(O5)[C@@H]4C3)O1)c1cc(O)c(O)c(O)c1 KLFIUQCKSSAFFU-QHOIGUMUSA-N 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000000589 Interleukin-1 Human genes 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010051602 Laziness Diseases 0.000 description 1
- 241000220645 Leonotis nepetifolia Species 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000124464 Paeonia veitchii Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000415073 Pulsatilla vulgaris subsp. grandis Species 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000589970 Spirochaetales Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 101710119418 Superoxide dismutase [Mn] Proteins 0.000 description 1
- 101710202572 Superoxide dismutase [Mn], mitochondrial Proteins 0.000 description 1
- 102100032891 Superoxide dismutase [Mn], mitochondrial Human genes 0.000 description 1
- YWJGYBXHXATAQY-UHFFFAOYSA-N Taraxerylacetat Natural products C12CCC3(C)C4CC(C)(C)CCC4(C)CC=C3C1(C)CCC1C2(C)CCC(OC(=O)C)C1(C)C YWJGYBXHXATAQY-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- XNRNNGPBEPRNAR-UHFFFAOYSA-N Thromboxane B2 Natural products CCCCCC(O)C=CC1OC(O)CC(O)C1CC=CCCCC(O)=O XNRNNGPBEPRNAR-UHFFFAOYSA-N 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 101100503357 Vigna unguiculata PFE2 gene Proteins 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- YWJGYBXHXATAQY-BOTWUFHUSA-N [(3s,4ar,6ar,6as,8ar,12ar,14ar,14br)-4,4,6a,6a,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl] acetate Chemical compound C([C@H]1[C@]2(C)CC[C@H]34)C(C)(C)CC[C@]1(C)CC=C2[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](OC(=O)C)C1(C)C YWJGYBXHXATAQY-BOTWUFHUSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 102000030621 adenylate cyclase Human genes 0.000 description 1
- 108060000200 adenylate cyclase Proteins 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- VIWQCBZFJFSCLC-UHFFFAOYSA-N alpha-benzoyloxypaeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(COC(=O)C=6C=CC=CC=6)O5)O)CC3(O)OC1C24COC(=O)C1=CC=C(O)C=C1 VIWQCBZFJFSCLC-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000000433 anti-nutritional effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001775 anti-pathogenic effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- 229960002986 dinoprostone Drugs 0.000 description 1
- 238000002828 disc diffusion antibiotic sensitivity testing Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 229940007078 entamoeba histolytica Drugs 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- KLFIUQCKSSAFFU-ANNBSXMPSA-N galloylpaeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@@]1(C[C@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](COC(=O)C=2C=C(O)C(O)=C(O)C=2)O1)O)C)OC(=O)C1=CC=CC=C1 KLFIUQCKSSAFFU-ANNBSXMPSA-N 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- WMRLNPAAXAUOIO-BGJNVIQHSA-N lactinolide Chemical compound C[C@@H]1[C@H]2C[C@H](O)[C@@](C)(O)C[C@H]2OC1=O WMRLNPAAXAUOIO-BGJNVIQHSA-N 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 229940097411 palm acid Drugs 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- XOKSLPVRUOBDEW-UHFFFAOYSA-N pinane group Chemical group C12C(CCC(C1(C)C)C2)C XOKSLPVRUOBDEW-UHFFFAOYSA-N 0.000 description 1
- 208000026438 poor feeding Diseases 0.000 description 1
- 208000007232 portal hypertension Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
- 230000036593 pulmonary vascular resistance Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- ZNMILUODKSYHAH-UHFFFAOYSA-N taraxeryl acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C2CCC4C5CC(C)(C)CCC5(C)CC=C34)C1(C)C ZNMILUODKSYHAH-UHFFFAOYSA-N 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种预防和治疗仔猪腹泻的中药组合物,属于兽药制备领域,它包括以下中药成份及重量份:白头翁8~12份、党参1~3份、赤芍1~3份、白术1~3份、干姜1~3份、陈皮1~3份、黄柏1~3份、甘草1~3份组成。本发明采用纯中草药材制成,来源广泛、成本低,治愈率高,药物无残留,无毒副作用,特别是同过水煎提取,保持了传统中药工艺、更易于吸收。具有显著的清热解毒、燥湿止痢、温补胃肠和调节机体机能的作用,有效治疗各类腹泻,缩短恢复期。使用方便。临床试验证明,治愈率达到85%以上,有独特疗效。A traditional Chinese medicine composition for preventing and treating piglet diarrhea, belonging to the field of veterinary drug preparation, comprising the following traditional Chinese medicinal ingredients in parts by weight: 8-12 parts of Pulsatilla pulsatillae, 1-3 parts of Codonopsis pilosula, 1-3 parts of Radix Paeoniae Rubra, and 1-3 parts of Atractylodes macrocephala , 1 to 3 parts of dried ginger, 1 to 3 parts of tangerine peel, 1 to 3 parts of Phellodendron cortex, and 1 to 3 parts of licorice. The invention is made of pure Chinese herbal medicinal materials, has wide sources, low cost, high cure rate, no drug residue, no toxic and side effects, especially the same decoction and extraction, which maintains the traditional Chinese medicine technology and is easier to absorb. It has obvious functions of clearing away heat and detoxifying, drying dampness and stopping dysentery, warming and tonifying the stomach and intestines, and regulating body functions. It can effectively treat various types of diarrhea and shorten the recovery period. Easy to use. Clinical trials have proved that the cure rate is over 85%, and it has a unique curative effect.
Description
技术领域technical field
本发明属于兽药制备领域,具体地涉及一种预防和治疗仔猪腹泻的中药组合及制备方法。The invention belongs to the field of veterinary drug preparation, and in particular relates to a traditional Chinese medicine combination for preventing and treating piglet diarrhea and a preparation method.
背景技术Background technique
仔猪腹泻是集约化养猪生产条件下的一种典型的多因素性疾病,该病是目前最严重的仔猪疾病群之一,也是引起仔猪死亡的重要原因。据报道,30kg以下的仔猪,全年平均发病率46.5%,死亡率10.3%。仔猪腹泻在养猪业危害中居首位,我国的仔猪死亡率一般为15~20%,经产母猪平均11~25%。病死仔猪80%以上为痢疾死亡。Piglet diarrhea is a typical multifactorial disease under intensive pig production conditions. It is one of the most serious piglet disease groups and an important cause of piglet death. According to reports, piglets below 30kg have an annual average incidence of 46.5% and a mortality rate of 10.3%. Piglet diarrhea ranks first in the hazards of the pig industry. The mortality rate of piglets in my country is generally 15-20%, and the average number of sows is 11-25%. More than 80% of dead piglets died of dysentery.
断奶仔猪腹泻病占仔猪腹泻很大比例,发病率很高,且一年四季都可流行。其发病原因很多,也非常复杂,但主要是应激反应造成的。仔猪早期断奶是指将传统的仔猪8周龄以后断奶提早到3~5周龄断奶的生产工艺,国外从60年代起已经逐步推广应用早期隔离断奶(SEW)。国内从70年代末、80年代初在一些大型猪场开始着手研究应用这种生产工艺,到80年代末、90年代初,一般的场都已基本实行仔猪3~4周龄断奶的方法。然而,早期断奶在生产上显示出极大潜力的同时,伴随而来的是由于早期断奶造成的应激,造成早期断奶综合征。临床上表现为断奶5天内食欲不振、饮欲增加、生长受阻、毛焦肚吊、腹泻、水肿等一系列临床症状。其中腹泻是最为常见也最为严重的一种现象。Weaning piglet diarrhea accounts for a large proportion of piglet diarrhea, and the incidence rate is very high, and it can be popular all year round. There are many reasons for its pathogenesis and are very complicated, but it is mainly caused by stress response. Early weaning of piglets refers to the production process of early weaning of piglets after 8 weeks of age to 3 to 5 weeks of age. Foreign countries have gradually promoted the application of early isolation weaning (SEW) since the 1960s. From the late 1970s and early 1980s in China, some large-scale pig farms began to study and apply this production process. By the late 1980s and early 1990s, the method of weaning piglets at the age of 3 to 4 weeks had been basically implemented in general farms. However, while early weaning shows great potential in terms of production, it is accompanied by stress due to early weaning, resulting in early weaning syndrome. Clinically, it is manifested as a series of clinical symptoms such as loss of appetite, increased desire to drink, growth retardation, hair burns, diarrhea, and edema within 5 days of weaning. Among them, diarrhea is the most common and serious phenomenon.
仔猪腹泻的原因复杂,归纳以起来大致分为以下几个方面:The causes of piglet diarrhea are complex and can be roughly divided into the following aspects:
1)自身发育不良导致消化功能、消化器官发育不全,从而影响仔猪正常吸收营养,导致发育受阻;断奶早,免疫力弱,对病原入侵的免疫应答能力弱,不能产生积极免疫应答,另外大量的外源性抗营养因子如球蛋白、β-聚球蛋白和蛋白质-碳水化合物复合物是造成仔猪胃肠道发生异常的免疫反应的主要的抗原物质;胃酸不足也可导致病原菌大量繁殖,引起消化吸收不良、腹泻下痢等疾病;另外消化道内消化酶的活性低,也会影响对饲料的消化和吸收。1) Self-developmental dysplasia leads to incomplete development of digestive function and digestive organs, which affects the normal absorption of nutrients of piglets, resulting in developmental obstruction; early weaning, weak immunity, weak immune response to pathogen invasion, unable to produce positive immune response, and a large number of piglets Exogenous anti-nutritional factors such as globulin, β-polyglobulin, and protein-carbohydrate complexes are the main antigenic substances that cause abnormal immune responses in the gastrointestinal tract of piglets; gastric acid deficiency can also lead to a large number of pathogenic bacteria, causing digestion Malabsorption, diarrhea and other diseases; in addition, the low activity of digestive enzymes in the digestive tract will also affect the digestion and absorption of feed.
2)外源性病原微生物感染,包括细菌如大肠杆菌、沙门氏菌、螺旋体等,病毒有仔猪腹泻病毒、传染性胃肠炎、轮状病毒等。2) Infection by exogenous pathogenic microorganisms, including bacteria such as Escherichia coli, Salmonella, spirochetes, etc. Viruses include piglet diarrhea virus, infectious gastroenteritis, rotavirus, etc.
中兽医认为引起仔猪腹泻的原因很多,但最主要还是由于饲养管理不良,气候多变,感受外邪,饮食所伤,脏腑虚衰及脏腑功能失调等因素引起。仔猪腹泻外因与湿盛的关系最为明显;内因与脾胃有关。由于脾喜燥恶湿,主食物和水之运化,脾气宜升;胃潮百脉,喜润恶燥,主腐熟,胃气宜降,两者共同完成“运化水谷,升清降浊”之功能。任何外邪或内伤因素影响脾胃功能,都能引起运化失调,腐熟无力,纳食不佳,清浊不分,传导失职,形成腹泻。因体虚或病久,损伤肾阳,致命火不足而无以脾土的阳气,则可加重病情。Chinese veterinarians believe that there are many reasons for diarrhea in piglets, but the most important ones are poor feeding management, changeable climate, exposure to exogenous pathogens, injury from diet, deficiency of viscera and dysfunction of viscera and other factors. The external cause of piglet diarrhea is most obviously related to dampness; the internal cause is related to the spleen and stomach. Because the spleen likes dryness and dislikes dampness, it is mainly used for the transportation and transformation of food and water, so the temper should be raised; the stomach is full of pulses, likes moistening and hates dryness, and it is mainly rotten, so the stomach qi should be lowered. "The function. Any exogenous evil or internal injury factors that affect the function of the spleen and stomach can cause disorders of transport and chemistry, weakness of rottenness, poor appetite, inability to distinguish between clear and turbid, conduction failure, and diarrhea. Due to physical deficiency or prolonged illness, kidney yang is damaged, and fatal fire is insufficient without the yang energy of the spleen and earth, which can aggravate the condition.
发明内容Contents of the invention
本发明提供了一种预防和治疗仔猪腹泻的中药组合及制备方法,本发明依据中兽医理论对仔猪腹泻辨证施治,筛选组方配伍,对仔猪腹泻的预防和治疗具有显著效果,且无毒副作用。The invention provides a combination of traditional Chinese medicines for preventing and treating piglet diarrhea and a preparation method. The invention treats piglet diarrhea based on syndrome differentiation and treatment based on the theory of traditional Chinese veterinary medicine, and screens the compatibility of the prescription, which has a significant effect on the prevention and treatment of piglet diarrhea, and is non-toxic. side effect.
本发明是通过以下技术方案实现的:The present invention is achieved through the following technical solutions:
一种预防和治疗仔猪腹泻的中药组合物,它包括以下中药成份及重量份:白头翁8~12份、党参1~3份、赤芍1~3份、白术1~3份、干姜1~3份、陈皮1~3份、黄柏1~3份、甘草1~3份组成。全方共奏清热解毒、健脾养胃、扶正祛邪、燥湿止痢之功效。A traditional Chinese medicine composition for preventing and treating diarrhea in piglets, comprising the following traditional Chinese medicine ingredients in parts by weight: 8-12 parts of Pulsatilla pulsatillae, 1-3 parts of Codonopsis pilosula, 1-3 parts of red peony root, 1-3 parts of Atractylodes macrocephala, and 1-3 parts of dried ginger 3 parts, 1 to 3 parts of tangerine peel, 1 to 3 parts of Cortex Phellodendri, and 1 to 3 parts of licorice. The whole prescription has the effects of clearing heat and detoxifying, invigorating the spleen and nourishing the stomach, strengthening the body and eliminating pathogenic factors, drying dampness and stopping dysentery.
一种预防和治疗仔猪腹泻的中药组合物的制备方法,将所述的8~12份白头翁、1~3份党参、1~3份赤芍、1~3份白术、1~3份干姜、1~3份陈皮、1~3份黄柏、1~3份甘草水煎浓缩液制备浸膏,提取后的药渣干燥后粉碎,过8~20目筛,得药渣粉,按浸膏:蔗糖粉(重量比)1:1比例在浸膏内加入蔗糖粉,搅拌均匀,根据干湿情况,添加药渣粉,搅拌均匀(以手捏成型为原则),后干燥制备成颗粒过8~20目筛,分装即得。A preparation method of a traditional Chinese medicine composition for preventing and treating diarrhea in piglets, comprising 8 to 12 parts of Pulsatilla grandis, 1 to 3 parts of Codonopsis pilosula, 1 to 3 parts of red peony root, 1 to 3 parts of Atractylodes macrocephala, and 1 to 3 parts of dried ginger . : sucrose powder (weight ratio) 1:1 ratio, add sucrose powder into the extract, stir evenly, add dregs powder according to the dryness and wetness, stir evenly (based on the principle of hand kneading), and then dry to prepare granules over 8 ~20-mesh sieve, then packed separately.
所述组合药物的使用方法,使用时按照每公斤饲料添加20~60克所述组合物,混饲,3~5天为一疗程。The method of using the combined medicine is to add 20-60 grams of the composition per kilogram of feed, and feed it mixedly, and a course of treatment is 3-5 days.
中草药防治仔猪腹泻病已经显示出良好势头,中草药不但可以防治仔猪腹泻病,还可解决药物残留问题,具有良好发展前景。如白头翁被证明是一种具有良好清热解毒、凉血止痢、燥湿止痢的功效,具有很高的药用价值,并且分布较广,我国各地均有生长,取材方便,价格低廉。The prevention and treatment of piglet diarrhea by Chinese herbal medicine has shown a good momentum. Chinese herbal medicine can not only prevent and treat piglet diarrhea, but also solve the problem of drug residues, and has a good development prospect. For example, Pulsatilla pulsatillae has been proven to have good effects of clearing heat and detoxifying, cooling blood and stopping dysentery, and drying dampness and stopping dysentery.
白头翁拉丁学名:Pulsatilla chinensis(Bunge)Regel),毛茛科,银莲花属多年生草本植物,长有根状茎,叶片呈卵形,花萼蓝紫色。别名有奈何草、粉乳草、白头草、老姑草等等。分布在中国的吉林、辽宁、河北、山东、河南、山西、陕西、黑龙江等省的山岗、荒坡及田野间,具有很高的药用价值。白头翁有清热解毒、凉血止痢、燥湿杀虫的功效。白头翁味苦,性寒;归胃、大肠经,主治热毒痢疾,鼻衄,血痔,带下,阴痒,痈疮,瘰疬。白头翁的药用作用主要包括:抗氧化、抗炎作用。Yao D等发现白头翁具有阻止肝组织中过氧化物的释放,增长MnSOD的活性,阻止乙型肝炎病毒的感染。龙盛京等利用鲁米诺发光体系,研究发现白头翁水提液具有较强的抗活性氧化作用,能有效清除过氧化氢,防止其所引起的脂质过氧化而造成细胞或组织损伤。张文远等研究发现白头翁醇提物对葡聚糖硫酸诱导的大鼠结肠炎具有明显的抑制作用。杀虫、抑菌作用。兰继毓等研究发现白头翁煎剂对杀灭溶组织内阿米巴的效果较好。曹景花等用K-B纸片扩散法测得白头翁水提液对金黄色葡萄球菌、绿脓杆菌、炭疽杆菌、伤寒杆菌、甲型链球菌、乙型链球菌具有明显的抑制作用。增强机体免疫功能。戴玲等在体外培养的小鼠腹腔巨噬细胞中加入不同浓度白头翁糖蛋白后,小鼠腹腔巨噬细胞吞噬中性红细胞的作用显著增强,并可诱生巨噬细胞产生一氧化碳,对巨噬细胞分泌IL-1亦有一定的提高作用。抗氧化作用。据最新研究表明,将白头翁5个糖基的皂苷改变成低糖皂苷,有利于人体吸收,并且白头翁皂苷的酶解产物可明显促进皮肤纤维芽细胞的胶原蛋白合成,以其混合制备抗衰老化妆品,可使皮肤中胶原蛋白量明显增加,有效改善皮肤弹性,抗皱纹,抗衰老。抗炎作用。慢性结肠炎为临床常见的疑难杂症之一。白头翁有镇痛、镇静、解痉及对肠黏膜有收敛止血作用。采用白头翁治疗慢性结肠炎可以增强机体免疫力,促进肠黏膜的修复。研究发现,白头翁汤治疗溃疡性结肠炎的机制在于其能够降低过亢的体液免疫及减少由细胞因子介导的免疫反应。Pulsatilla Latin scientific name: Pulsatilla chinensis (Bunge) Regel), Ranunculaceae, Anemone is a perennial herb with rhizomes, ovate leaves, and blue-purple calyx. Aliases include Naihe grass, pink milk grass, bald head grass, old aunt grass and so on. Distributed in hills, barren slopes and fields in Jilin, Liaoning, Hebei, Shandong, Henan, Shanxi, Shaanxi, Heilongjiang and other provinces in China, it has high medicinal value. Pulsatilla has the effects of clearing away heat and detoxification, cooling blood and stopping dysentery, drying dampness and killing insects. Pulsatillae bitter in the mouth, cold in nature; returns stomach, large intestine meridian, cures mainly heat-toxic dysentery, epistaxis, blood hemorrhoid, leukorrhagia, pruritus vulvae, carbuncle sore, scrofula. The medicinal effects of Pulsatillae mainly include: anti-oxidation and anti-inflammatory effects. Yao D et al. found that Pulsatilla can prevent the release of peroxides in liver tissue, increase the activity of MnSOD, and prevent the infection of hepatitis B virus. Long Shengjing et al. used the luminol luminescent system to study and found that the water extract of Pulsatilla chinensis has a strong anti-active oxidation effect, can effectively remove hydrogen peroxide, and prevent cell or tissue damage caused by lipid peroxidation caused by it. Zhang Wenyuan et al found that Pulsatillae Alcohol Extract had a significant inhibitory effect on dextran sulfate-induced colitis in rats. Insecticidal and antibacterial effects. Lan Jiyu et al found that Pulsatilla decoction has a better effect on killing Entamoeba histolytica. Cao Jinghua et al. used the K-B disc diffusion method to measure that the water extract of Pulsatillae had obvious inhibitory effects on Staphylococcus aureus, Pseudomonas aeruginosa, Bacillus anthracis, Bacillus typhi, Streptococcus A, and Streptococcus B. Enhance the immune function of the body. Dai Ling et al. added different concentrations of Pulsatilla glycoprotein to mouse peritoneal macrophages cultured in vitro, the phagocytosis of neutrophils by mouse peritoneal macrophages was significantly enhanced, and the macrophages could be induced to produce carbon monoxide, which had an effect on macrophages. Cell secretion of IL-1 also has a certain role in improving. Anti-oxidize effect. According to the latest research, changing the saponins of 5 glycosides of Pulsatillae Radix into low-sugar saponins is beneficial to human body absorption, and the enzymatic hydrolysis products of Pulsatillae Radix Saponins can significantly promote the synthesis of collagen in skin fibroblast cells, and prepare anti-aging cosmetics by mixing them. It can significantly increase the amount of collagen in the skin, effectively improve skin elasticity, anti-wrinkle, and anti-aging. Anti-inflammatory effect. Chronic colitis is one of the common intractable diseases in clinic. Pulsatilla has analgesic, sedative, antispasmodic and astringent hemostatic effects on intestinal mucosa. The treatment of chronic colitis with Pulsatilla can enhance the body's immunity and promote the repair of intestinal mucosa. Studies have found that the mechanism of Pulsatilla Decoction in treating ulcerative colitis lies in its ability to reduce excessive humoral immunity and reduce immune responses mediated by cytokines.
党参(学名;Codonopsis pilosula)呈椭圆形或类圆形的厚片,表面黄棕色或灰黄色,切面黄白色或黄棕色,有裂隙或菊花纹,中央有淡黄色圆心。周边淡黄白色置黄棕色,有纵皱纹。有特殊香气,味微甜。产地中国北方海拔1560-3100米的山地林边及灌丛中。党参属植物全世界约有40种,中国约有39种,药用有21种、4变种。党参为中国常用的传统补益药,古代以山西上党地区出产的党参为上品,具有补中益气,健脾益肺之功效。现代研究,党参有增强免疫力、扩张血管、降压、改善微循环、增强造血功能等作用。此外对化疗放疗引起的白细胞下降有提升作用。Codonopsis pilosula (scientific name; Codonopsis pilosula) is oval or sub-circular thick slice, the surface is yellow-brown or gray-yellow, the cut surface is yellow-white or yellow-brown, with cracks or chrysanthemum patterns, and a light yellow center in the center. Periphery pale yellowish white to yellowish brown, with longitudinal wrinkles. It has a special aroma and slightly sweet taste. It is grown in mountain forests and shrubs at an altitude of 1560-3100 meters in northern China. There are about 40 species of Codonopsis genus plants in the world, about 39 species in China, 21 species and 4 varieties for medicinal purposes. Codonopsis Codonopsis is a traditional tonic medicine commonly used in China. In ancient times, Codonopsis Codonopsis produced in Shangdang area of Shanxi was the top grade. It has the effects of nourishing the middle and Qi, strengthening the spleen and lungs. According to modern research, Codonopsis pilosula has the effects of enhancing immunity, dilating blood vessels, lowering blood pressure, improving microcirculation, and enhancing hematopoietic function. In addition, it can improve the leukopenia caused by chemotherapy and radiotherapy.
生党参片益气生津力胜。常用于气津两伤或气血两亏。党参味甘,性平。有补中益气、止渴、健脾益肺,养血生津。用于脾肺气虚,食少倦怠,咳嗽虚喘,气血不足,面色萎黄,心悸气短,津伤口渴,内热消渴,懒言短气、四肢无力、食欲不佳、气虚、气津两虚、气血双亏以及血虚萎黄等症。但表证未解而中满邪实的不能用。该品功效与人参相似,惟药力薄弱。治一般虚证,可代替人参使用;虚脱重证,则仍用人参为宜。秋季采挖,洗净,晒干。Raw Dangshen Tablets benefit Qi and promote body fluid. It is often used for qi-jin injury or qi-blood deficiency. Codonopsis is sweet in taste and flat in nature. There are invigorating vital energy, quenching thirst, invigorating the spleen and lungs, nourishing blood and promoting body fluid. It is used for deficiency of spleen and lung qi, lack of food and fatigue, cough and shortness of breath, lack of qi and blood, sallow complexion, palpitation, shortness of breath, thirsty body fluid wound, internal heat and thirst, laziness and shortness of breath, weakness of limbs, poor appetite, deficiency of qi, and dual qi and body fluid. Deficiency, qi and blood deficiency, and blood deficiency and chlorosis embolism. However, it cannot be used if the evidence is not clear and the middle is full of evil. The effect of this product is similar to that of ginseng, but its medicinal power is weak. It can be used instead of ginseng to treat general deficiency syndromes; it is still advisable to use ginseng for severe collapse syndromes. Excavated in autumn, washed and dried in the sun.
赤芍为毛茛科芍药(Paeonia lactifloraPal.l)或川赤芍(P.veitchiiLynch.)的干燥根。其味苦,微寒,归肝经,具有清热凉血,散瘀镇痛之功效。主要成分包括具蒎烷结构的单萜及其苷类,该类化合物有芍药苷、羟基芍药苷、苯甲酰芍药苷、苯甲酰羟基芍药苷、羟基苯甲酰芍药苷、芍药新苷、8(Z)-(1S,5R)-B蒎烯-10-羟基-B-巢菜糖苷、芍药内酯苷等;具内酯结构的单萜及其苷类,该类化合物有芍药内酯A、B、C;Lactinolide、6-O-B-D-glucopyranosyl-lactinolide等。另外尚有氧化芍药苷、芍药花苷、芍药苷元、没食子酰芍药苷等。Radix Paeoniae Rubra is the dried root of Paeonia lactifloraPal.l or P.veitchiiLynch. It is bitter in the mouth, slightly cold, and returns to the liver meridian, has the effects of clearing away heat and cooling blood, dispelling blood stasis and relieving pain. The main components include monoterpenes with a pinane structure and their glycosides, such compounds include paeoniflorin, hydroxypaeoniflorin, benzoylpaeoniflorin, benzoylhydroxypaeoniflorin, hydroxybenzoylpaeoniflorin, paeoniflorin, 8(Z)-(1S,5R)-B-pinene-10-hydroxy-B-nestrel glycoside, paeonifloride glycoside, etc.; monoterpene with lactone structure and its glycosides, such compounds include paeonifloride A, B, C; Lactinolide, 6-O-B-D-glucopyranosyl-lactinolide, etc. In addition, there are oxidized paeoniflorin, paeoniflorin, paeoniflorin, galloyl paeoniflorin and so on.
赤芍的药理作用包括对血液系统的作用。药理学研究表明赤芍抑制血小板聚集,改善红细胞的通透性,增加红细胞对低渗张力的抗性,有一定稳定红细胞膜结构的作用。另外,赤芍总苷能明显延长大鼠和小鼠的凝血时间,并能延长电刺激大鼠颈总动脉血栓形成的时间,提示赤芍总苷通过对凝血系统和血小板功能的影响而产生抗血栓作用。对心血管的作用。赤芍是传统的活血化瘀类中药,有较强的抗动脉粥样硬化作用,该药也能扩张冠脉血管,增加冠脉血流量从而增加心肌营养性血流量;保护缺血心肌,提高心肌对低氧的耐受性;降低肺血管阻力,减轻后负荷。同时赤芍能够降低门脉高压,对微循环也有影响。对肿瘤的作用。芍药苷能抑制肿瘤细胞膜上三磷腺苷(ATP)酶的活性及升高腺苷酸环化酶活性的作用。朱剑华等对赤芍水溶性提取液进行了诱变性和抗诱变性实验,结果显示赤芍水溶性提取液存在明显的抗诱变作用,且随浓度的增加而增强。对肝脏的作用。赤芍等活血化瘀药具有消退黄疸、抑制血浆中血栓素B2产生、促进肝脏水解、抗肝纤维化、促进肝细胞再生的作用。赤芍还具有抗炎、抗变态反应作用,清除活性氧自由基的作用,还具有滋补强壮作用,对神经系统也有一定作用。The pharmacological effects of Radix Paeoniae Rubra include effects on the blood system. Pharmacological studies have shown that Radix Paeoniae Rubra inhibits platelet aggregation, improves the permeability of red blood cells, increases the resistance of red blood cells to hypotonic tension, and has a certain effect on stabilizing the membrane structure of red blood cells. In addition, total glucosides of paeony can significantly prolong the coagulation time of rats and mice, and can prolong the time of electrical stimulation of rat common carotid artery thrombosis, suggesting that total glucosides of paeony exert anti-inflammatory effects through the influence of coagulation system and platelet function. Thrombosis. effect on cardiovascular. Radix Paeoniae Rubra is a traditional traditional Chinese medicine for promoting blood circulation and removing blood stasis. It has a strong anti-atherosclerosis effect. The drug can also expand coronary vessels, increase coronary blood flow and thereby increase myocardial nutritional blood flow; Myocardial tolerance to hypoxia; reduce pulmonary vascular resistance, reduce afterload. At the same time, Radix Paeoniae Rubra can reduce portal hypertension and also affect microcirculation. effect on tumors. Paeoniflorin can inhibit the activity of adenosine triphosphate (ATP) enzyme on the tumor cell membrane and increase the activity of adenylate cyclase. Zhu Jianhua et al. conducted mutagenic and anti-mutagenic experiments on the water-soluble extract of Radix Paeoniae Rubra, and the results showed that the water-soluble extract of Radix Paeoniae Rubra had obvious anti-mutagenic effects, and it was enhanced with the increase of concentration. effect on the liver. Radix Paeoniae Rubra and other blood-activating and stasis-removing drugs have the effects of reducing jaundice, inhibiting the production of thromboxane B2 in plasma, promoting liver hydrolysis, resisting liver fibrosis, and promoting liver cell regeneration. Radix Paeoniae Rubra also has anti-inflammation, anti-allergic effects, the effect of scavenging active oxygen free radicals, also has the effect of nourishing and strengthening, and also has a certain effect on the nervous system.
白术为我国常用中药之一,为菊科植物白术Atractylodes macrocephalaKoidz.的干燥根茎,性温,味甘、苦,具有健脾益气、燥湿利水、止汗、安胎的功效,用于治疗脾胃气弱、泄泻、汗出、胎动不安等。主产于浙江、安徽,以浙江鄞县、新昌地区产量最大,於潜所产品质最佳,特称为“於术”,具有补脾、益胃、燥湿、和中的功效。白术的化学成分较为复杂,现已知主要含有挥发油、内酯类、多糖类。挥发油在白术根茎中约含1.4%,其主要成分为苍术酮(atratylon)、苍术醇等,白术用乙醇渗漉提取,硅胶色谱分离,再用石油醚-乙醚梯度洗脱,得到白术内酯Ⅰ(atractylenolideⅠ)、白术内酯Ⅱ(atractylenolideⅡ)、白术内酯Ⅲ(atractyl-enolideⅢ)、8B-乙氧基白术内酯Ⅲ(8B-ethoxyatractylenolideⅢ)。白术中含有白术多糖PM、甘露聚糖Am-3等。将白术水提沉物经732强酸型阳离子交换树脂、硼酸型DEAE-cellulose柱分离得到PSAM-1、PSAM-2两个杂多糖。除此之外,白术中还含有12A-甲基丁酰-14-乙酰-8-顺白术三醇、12A-甲基丁酰-14乙酰-8-反白术三醇、14A-甲基丁酰-8-顺白术三醇、14A-甲基丁酰-8-反白术三醇[5]、白术内酰胺(atratylenolactam)、蒲公英萜醇乙酸酯(taraxerylacetate)、杜松脑(junipercomphor)、棕榈酸、B-香树素乙酸酯、C-谷甾醇、B-谷甾醇、C-菠甾醇。白术里还含有谷氨酸等14种氨基酸及树脂、维生素A等多种物质。Atractylodes macrocephala is one of the commonly used traditional Chinese medicines in my country. It is the dry rhizome of Atractylodes macrocephala Koidz. of Compositae. It is warm in nature, sweet in taste and bitter in taste. Weakness of breath, diarrhea, sweating, restless fetal movement, etc. It is mainly produced in Zhejiang and Anhui, with the largest output in Yinxian and Xinchang, Zhejiang. The quality of Yuqian is the best. It is specially called "Yushu". The chemical composition of Atractylodes macrocephala is relatively complex, and it is known that it mainly contains volatile oil, lactones, and polysaccharides. The volatile oil in the rhizome of Atractylodes Rhizome contains about 1.4%, and its main components are atratylon, atractylodes alcohol, etc. Atractylodes atractylodes is extracted by percolation with ethanol, separated by silica gel chromatography, and then eluted with petroleum ether-ether gradient to obtain Atractylodes lactone Ⅰ (atractylenolide Ⅰ), atractylenolide Ⅱ (atractylenolide Ⅱ), atractyl-enolide Ⅲ (atractyl-enolide Ⅲ), 8B-ethoxy atractylenolide Ⅲ (8B-ethoxyatractylenolide Ⅲ). Atractylodes macrocephala contains Atractylodes polysaccharide PM, mannan Am-3 and so on. Two heteropolysaccharides, PSAM-1 and PSAM-2, were obtained by separating the extract and sediment of Atractylodes Rhizoma Atractylodes Rhizome through 732 strong-acid cation exchange resin and boric acid-type DEAE-cellulose column. In addition, Atractylodes macrocephala also contains 12A-methylbutyryl-14-acetyl-8-cis-atractyltriol, 12A-methylbutyryl-14-acetyl-8-trans-atractyltriol, 14A-methylbutyryl -8-cis-atractyltriol, 14A-methylbutyryl-8-trans-atractyltriol[5], atratylenolactam, taraxerylacetate, junipercomphor, palm Acid, B-myringin acetate, C-sitosterol, B-sitosterol, C-spinasterol. Atractylodes macrocephala also contains 14 kinds of amino acids such as glutamic acid, resin, vitamin A and other substances.
白术是最常用的补气药,具有补脾益气、燥湿利水、固表止汗的功效,近代药理学研究表明白术具有免疫调节、利尿、抗肿瘤、抗菌消炎、降糖、抗衰老等作用,对神经系统、消化道、子宫平滑肌也有一定作用,还能调节免疫功能。Atractylodes macrocephala is the most commonly used medicine for invigorating qi. It has the effects of invigorating the spleen and replenishing qi, drying dampness and diuresis, strengthening the surface and antiperspirant. Modern pharmacological studies have shown that Atractylodes macrocephala has immune regulation, diuretic, anti-tumor, antibacterial and anti-inflammatory, hypoglycemic, anti-aging, etc. It also has a certain effect on the nervous system, digestive tract, and uterine smooth muscle, and can also regulate immune function.
黄柏又名关黄柏,川黄柏;蒙药名:霞日毛都,为芸香科植物黄皮树Phellodendron chinense Schneid.或黄檗Phello-dendron amurense Rupr的干燥树皮。黄树皮主产我国四川、贵州等省。黄檗主产吉林、辽宁、黑龙江等省。中医学认为:黄柏性寒味苦,主肾、膀胱经,具有清热燥湿、泻火解毒、清退虚热的功效,主要用来治疗胃肠道疾病。研究表明,黄柏具有抗病原微生物作用:根据[PhytotherRes]记载,黄柏和黄连的醇提取物对二甲苯诱发的小鼠耳廓炎症有明显的抑制作用(P<0.05);复方黄柏液静脉推注200mg(kg),产生与静注地塞米松100mlPmg同样的抑菌作用。黄柏对胃溃疡具有抑制作用:有实验证明,除去生物碱的黄柏水溶性成分可抑制水浸拘束应激小鼠SOD活性的降低,可使水浸前PFE2量显著增加,并有抑制水浸后PGE2量减少的趋势。说明其对胃溃疡有抑制作用。Phellodendron phellodendron, also known as Phellodendron chinense Schneid. or Phello-dendron amurense Rupr, is the dry bark of Phellodendron chinense Schneid. or Phello-dendron amurense Rupr. Yellow bark is mainly produced in Sichuan, Guizhou and other provinces of my country. Phellodendron amurense is mainly produced in Jilin, Liaoning, Heilongjiang and other provinces. Traditional Chinese medicine believes that Cortex Phellodendri is cold in nature and bitter in taste, governs the kidney and bladder meridians, has the effects of clearing away heat and dampness, purging fire and detoxification, and clearing away asthenic heat. It is mainly used to treat gastrointestinal diseases. Studies have shown that Phellodendron Phellodendri has anti-pathogenic microorganisms: according to [PhytotherRes] records, the alcohol extracts of Phellodendron Phellodendri and Coptis Rhizoma have obvious inhibitory effect on mouse auricle inflammation induced by xylene (P<0.05); Inject 200mg (kg), produce the same antibacterial effect as intravenous dexamethasone 100mlPmg. Phellodendron Phellodendri has inhibitory effect on gastric ulcer: Experiments have proved that the water-soluble components of Phellodendron Phellodendron without alkaloids can inhibit the reduction of SOD activity in water immersion restraint stress mice, can significantly increase the amount of PFE2 before water immersion, and inhibit the water immersion after water immersion. The trend of reducing the amount of PGE2. It shows that it has inhibitory effect on gastric ulcer.
中药组合物的配伍需要依据中兽医理论对疾病进行辨证施治,筛选组方,合理配伍,才能达到对疾病的预防和治疗具有显著效果。因此,配伍不同的药物所体现的药理作用也不同。上述白头翁、党参、赤芍、白术、干姜、陈皮、黄柏、甘草等药物相伍,全方共奏清热解毒、健脾养胃、扶正祛邪、燥湿止痢之功效。The compatibility of the traditional Chinese medicine composition needs to treat the disease according to the theory of traditional Chinese veterinary medicine based on syndrome differentiation, screening of prescriptions, and reasonable compatibility, so as to achieve a significant effect on the prevention and treatment of the disease. Therefore, the pharmacological effects of drugs with different compatibility are also different. The above-mentioned pulsatilla, codonopsis, red peony, Atractylodes macrocephala, dried ginger, tangerine peel, Phellodendron cortex, licorice and other medicines are combined together, and the whole prescription has the effects of clearing away heat and detoxification, strengthening the spleen and nourishing the stomach, strengthening the body and eliminating pathogens, drying dampness and stopping dysentery.
本发明与现有技术相比的有益效果:本发明以抗菌消炎、止痢止血、提高机体免疫力、修复肠道功能为治则,组方合理,制备工艺简单,适用范围广。本发明采用纯中草药材制成,来源广泛、成本低,治愈率高,药物无残留,无毒副作用,特别是同过水煎提取,保持了传统中药工艺、更易于吸收。具有显著的清热解毒、燥湿止痢、温补胃肠和调节机体机能的作用,有效治疗各类腹泻,缩短恢复期。使用方便。临床试验证明,治愈率达到85%以上,有独特疗效。The beneficial effect of the present invention compared with the prior art: the present invention is based on the principles of antibacterial and anti-inflammation, stopping dysentery and hemostasis, improving body immunity, and repairing intestinal function. The composition is reasonable, the preparation process is simple, and the application range is wide. The invention is made of pure Chinese herbal medicinal materials, has wide sources, low cost, high cure rate, no drug residue, no toxic and side effects, especially the same decoction and extraction, which maintains the traditional Chinese medicine technology and is easier to absorb. It has obvious functions of clearing away heat and detoxifying, drying dampness and stopping dysentery, warming and tonifying the stomach and intestines, and regulating body functions. It can effectively treat various types of diarrhea and shorten the recovery period. Easy to use. Clinical trials have proved that the cure rate is over 85%, and it has a unique curative effect.
具体实施方式Detailed ways
以下结合较佳实施例,对依据本发明提供的具体实施方式详述如下:Below in conjunction with preferred embodiment, the specific implementation mode provided according to the present invention is described in detail as follows:
实施例1Example 1
按重量比8000g:1000g:1000g:1000g:1000g:1000g:1000g:1000g,称取白头翁、党参、赤芍、白术、干姜、陈皮、黄柏、甘草,将以上八味中草药加水煎煮2次,每次0.5小时,合并煎液,滤过,滤液浓缩得浸膏,提取后的药渣干燥后粉碎,过8目筛,得药渣粉。按浸膏:蔗糖粉(重量比)1:1比例在浸膏内加入蔗糖粉,搅拌均匀,添加适量药渣粉,搅拌均匀至手捏成块,后干燥制备成颗粒过10目筛,干燥后分装;用于预防和治疗各类仔猪腹泻病时,在饲料中按照每公斤饲料添加10g,混饲,连用3天。According to the weight ratio of 8000g: 1000g: 1000g: 1000g: 1000g: 1000g: 1000g: 1000g, weigh Pulsatilla, Codonopsis Radix, Radix Paeoniae Rubra, Atractylodes Rhizoma Atractylodes Rhizome, Dried Ginger, Tangerine Peel, Phellodendron Phellodendri, and Licorice, and decoct the above eight Chinese herbal medicines with water twice, Combine the decoctions for 0.5 hours each time, filter, concentrate the filtrate to obtain extracts, dry and pulverize the extracted medicinal residues, and pass through an 8-mesh sieve to obtain medicinal residues powder. According to extract: sucrose powder (weight ratio) 1:1 ratio, add sucrose powder into the extract, stir evenly, add appropriate amount of dregs powder, stir evenly until hand-kneaded into pieces, and then dry to prepare granules, pass through a 10-mesh sieve, and dry Subpackaged afterwards; when used to prevent and treat various types of piglet diarrhea, add 10g per kilogram of feed to the feed, mix feed, and use continuously for 3 days.
实施例2Example 2
按重量比9000g:1500g:1500g:1000g:1000g:1000g:1000g:1000g,称取白头翁、党参、赤芍、白术、干姜、陈皮、黄柏、甘草,将以上八味中草药加水煎煮2次,每次0.5小时,合并煎液,滤过,滤液浓缩得浸膏,提取后的药渣干燥后粉碎,过10目筛,得药渣粉。按浸膏:蔗糖粉(重量比)1:1比例在浸膏内加入蔗糖粉,搅拌均匀,添加适量药渣粉,搅拌均匀至手捏成块,后干燥制备成颗粒过15目筛,干燥后分装。用于预防和治疗各类仔猪腹泻病时,在饲料中按照每公斤饲料添加20g,混饲,连用4天。According to the weight ratio of 9000g: 1500g: 1500g: 1000g: 1000g: 1000g: 1000g: 1000g, weigh Pulsatilla, Codonopsis, Radix Paeoniae Rubra, Atractylodes Rhizoma Atractylodes Rhizome, Dried Ginger, Tangerine Peel, Phellodendron Phellodendri, and Licorice, and decoct the above eight Chinese herbal medicines with water twice, Combine the decoctions for 0.5 hours each time, filter, concentrate the filtrate to obtain extracts, dry and pulverize the extracted medicinal residues, and pass through a 10-mesh sieve to obtain medicinal residues powder. According to the extract: sucrose powder (weight ratio) 1:1 ratio, add sucrose powder to the extract, stir evenly, add appropriate amount of dregs powder, stir evenly until hand-kneaded into pieces, and then dry to prepare granules, pass through a 15-mesh sieve, and dry Subpackage later. When used to prevent and treat various types of piglet diarrhea, add 20g per kilogram of feed to the feed, and mix it for 4 consecutive days.
实施例3Example 3
按重量比10000g:2000g:1000g:1500g:1500g:1500g:1500g:1500g,称取白头翁、党参、赤芍、白术、干姜、陈皮、黄柏、甘草,将以上八味中草药加水煎煮2次,每次0.5小时,合并煎液,滤过,滤液浓缩得浸膏,提取后的药渣干燥后粉碎,过15目筛,得药渣粉。按浸膏:蔗糖粉(重量比)1:1比例在浸膏内加入蔗糖粉,搅拌均匀,添加适量药渣粉,搅拌均匀至手捏成块,后干燥制备成颗粒过20目筛,干燥后分装。用于预防和治疗各类仔猪腹泻病时,在饲料中按照每公斤饲料添加30g,混饲,连用5天。According to the weight ratio of 10000g: 2000g: 1000g: 1500g: 1500g: 1500g: 1500g: 1500g, weigh Pulsatilla, Codonopsis, Radix Paeoniae Rubra, Atractylodes Rhizoma Atractylodes Rhizome, Dried Ginger, Tangerine Peel, Phellodendron Phellodendri, and Licorice, and decoct the above eight Chinese herbal medicines with water twice, Combine the decoctions for 0.5 hours each time, filter, concentrate the filtrate to obtain extracts, dry and pulverize the extracted medicinal residues, and pass through a 15-mesh sieve to obtain medicinal residues powder. According to extract: sucrose powder (weight ratio) 1:1 ratio, add sucrose powder into the extract, stir evenly, add appropriate amount of dregs powder, stir evenly until hand-kneaded into pieces, and then dry to prepare granules, pass through a 20-mesh sieve, and dry Subpackage later. When used to prevent and treat various types of piglet diarrhea, add 30g per kilogram of feed to the feed, and mix it for 5 consecutive days.
实施例4Example 4
按重量比10000g:2000g:1000g:1500g:1500g:1500g:1500g:1500g,称取白头翁、党参、赤芍、白术、干姜、陈皮、黄柏、甘草,将以上八味中草药加水煎煮2次,每次0.5小时,合并煎液,滤过,滤液浓缩得浸膏,提取后的药渣干燥后粉碎,过20目筛,得药渣粉。按浸膏:蔗糖粉(重量比)1:1比例在浸膏内加入蔗糖粉,搅拌均匀,添加适量药渣粉,搅拌均匀至手捏成块,后干燥制备成颗粒过20目筛,干燥后分装。用于预防和治疗各类仔猪腹泻病时,在饲料中按照每公斤饲料添加30g,混饲,连用5天。According to the weight ratio of 10000g: 2000g: 1000g: 1500g: 1500g: 1500g: 1500g: 1500g, weigh Pulsatilla, Codonopsis, Radix Paeoniae Rubra, Atractylodes Rhizoma Atractylodes Rhizome, Dried Ginger, Tangerine Peel, Phellodendron Phellodendri, and Licorice, and decoct the above eight Chinese herbal medicines with water twice, Each time for 0.5 hours, the decoctions were combined, filtered, and the filtrate was concentrated to obtain an extract, and the extracted dregs were dried and pulverized, and passed through a 20-mesh sieve to obtain a dregs powder. According to extract: sucrose powder (weight ratio) 1:1 ratio, add sucrose powder into the extract, stir evenly, add appropriate amount of dregs powder, stir evenly until hand-kneaded into pieces, and then dry to prepare granules, pass through a 20-mesh sieve, and dry Subpackage later. When used to prevent and treat various types of piglet diarrhea, add 30g per kilogram of feed to the feed, and mix it for 5 consecutive days.
临床试验:Clinical Trials:
实例1:Example 1:
福山某种猪场,长白猪Some kind of pig farm in Fushan, Landrace pigs
该场饲养长白仔猪1000头,断奶后3天大约死亡150头(死亡率15%),另外200头左右出现腹泻、拉水样粪便,食欲不振。临床及实验室诊断为大肠杆菌引起的细菌性仔猪腹泻,100头的发病仔猪口服抗生素如恩诺沙星等,康复30头,死亡15头,尚有55头发病。由于无法彻底治愈,最后这部分仔猪淘汰。其余100头发病仔猪口服实施例1的药物组合物,4天后发病仔猪降至15头,死亡5头,其余80头康复并饲养至150天,全部出栏。The farm raised 1,000 Landrace piglets, about 150 of which died 3 days after weaning (15% mortality rate), and another 200 or so had diarrhea, watery feces, and loss of appetite. The clinical and laboratory diagnosis was bacterial piglet diarrhea caused by Escherichia coli. 100 affected piglets were given oral antibiotics such as enrofloxacin, 30 recovered, 15 died, and 55 remained ill. Due to the inability to be completely cured, the last part of the piglets was eliminated. The remaining 100 sick piglets were given the pharmaceutical composition of Example 1 orally. After 4 days, the number of sick piglets dropped to 15, and 5 died. The remaining 80 piglets recovered and were reared for 150 days before being slaughtered.
对未发病的仔猪全部口服实施例1的药物组合物,未出现仔猪腹泻症状,饲养至150天,全部出栏。The pharmaceutical composition of Example 1 was given orally to all piglets without disease, and no symptoms of diarrhea occurred in the piglets, and they were fed to 150 days, and all piglets were slaughtered.
实例2:Example 2:
烟台莱阳某种猪场,杜洛克猪Some kind of pig farm in Laiyang, Yantai, Duroc pigs
该场饲养仔猪1500头,断奶后2天500头出现下痢、拉水样粪便,食欲不振,死亡210头。临床及实验室诊断为轮状病毒感染的仔猪腹泻病,250头发病仔猪口服抗生素恩诺沙星等,康复45头,死亡75头,尚有130头发病。另250头发病仔猪口服实施例2的药物组合物,3天以后发病仔猪降至10头,死亡3头,其余237头康复,饲喂至150天最后全部健康出栏。后又饲养一批至断奶3天时,出现同样临床症状,判断为轮状病毒感染后,全群口服使用发明实施例2的药物组合物及使用方法,3天后腹泻病情得到控制,仔猪仅死亡5头,效果明显。The farm raised 1,500 piglets, 500 of which had diarrhea, watery feces, and loss of appetite 2 days after weaning, and 210 of them died. The clinical and laboratory diagnosis was piglet diarrhea caused by rotavirus infection. 250 affected piglets were given antibiotics such as enrofloxacin. 45 piglets recovered, 75 piglets died, and 130 piglets remained ill. Another 250 diseased piglets took the pharmaceutical composition of Example 2 orally. After 3 days, the diseased piglets were reduced to 10, 3 died, and the remaining 237 recovered. They were fed to 150 days and finally all healthy for slaughter. After raising another batch until 3 days after weaning, the same clinical symptoms appeared. After judging as rotavirus infection, the whole group took the pharmaceutical composition of the invention embodiment 2 and the method of use orally, and the diarrhea condition was controlled after 3 days, and only 5 piglets died. Head, the effect is obvious.
实例3:Example 3:
烟台某种猪场,地方品种黑山猪A certain pig farm in Yantai, the local breed of black mountain pig
该场饲养仔猪2000头,断奶后2天900头出现下痢、拉水样粪便,食欲不振,死亡310头。临床及实验室诊断为仔猪腹泻病毒感染的仔猪腹泻,300头发病仔猪口服抗生素恩诺沙星等,,康复60头,死亡90头,尚有150头发病。另300头发病仔猪口服实施例3的药物组合物,3天以后发病仔猪降至12头,死亡5头,其余283头康复,饲喂至150天最后全部健康出栏。剩余300头口服实施例4的药物,3天以后发病仔猪降至8头,死亡3头,其余289头康复,饲喂至150天最后全部健康出栏。后又饲养一批至断奶后2天时,出现同样临床症状,判断为轮状病毒感染后,一半口服使用发明实施例3的药物组合物及使用方法,另一半使用发明实施例3的药物组合物及使用方法,3天后腹泻病情得到控制,仔猪仅死亡5头,效果明显。The farm raised 2,000 piglets, 900 piglets had diarrhea, watery feces, and loss of appetite 2 days after weaning, and 310 piglets died. Clinical and laboratory diagnosis of piglet diarrhea virus-infected piglets, 300 diseased piglets oral antibiotics such as enrofloxacin, 60 recovered, 90 died, and 150 still sick. Another 300 diseased piglets took the pharmaceutical composition of Example 3 orally. After 3 days, the diseased piglets were reduced to 12, 5 died, and the remaining 283 recovered. They were fed to 150 days and finally all healthy for slaughter. Remaining 300 orally took the medicine of embodiment 4, and 3 days later, the diseased piglets were reduced to 8, and 3 died, and the remaining 289 recovered, fed to 150 days, and finally all healthy piglets were slaughtered. After raising another batch until 2 days after weaning, the same clinical symptoms appeared. After judging that they were infected with rotavirus, half of them took the pharmaceutical composition and the method of use of the invention embodiment 3 orally, and the other half used the pharmaceutical composition of the invention embodiment 3 And the method of use, the diarrhea condition was controlled after 3 days, and only 5 piglets died, and the effect was obvious.
本发明药物无毒副作用,使用方便。The medicine of the invention has no toxic and side effects and is convenient to use.
上述参照实施例对预防和治疗仔猪腹泻的中药组合物进行的详细描述,是说明性的而不是限定性的,可按照所限定范围列举出若干个实施例,因此在不脱离本发明总体构思下的变化和修改,应属本发明的保护范围之内。The above-mentioned detailed description of the Chinese medicine composition for preventing and treating piglet diarrhea with reference to the examples is illustrative rather than limiting, and several examples can be listed according to the limited scope, so without departing from the general concept of the present invention Changes and modifications should fall within the protection scope of the present invention.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510317143.XA CN104840934A (en) | 2015-06-11 | 2015-06-11 | Traditional Chinese medicine composition for preventing and treating piglet diarrhea and preparation method of traditional Chinese medicine composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510317143.XA CN104840934A (en) | 2015-06-11 | 2015-06-11 | Traditional Chinese medicine composition for preventing and treating piglet diarrhea and preparation method of traditional Chinese medicine composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104840934A true CN104840934A (en) | 2015-08-19 |
Family
ID=53841179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510317143.XA Pending CN104840934A (en) | 2015-06-11 | 2015-06-11 | Traditional Chinese medicine composition for preventing and treating piglet diarrhea and preparation method of traditional Chinese medicine composition |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104840934A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104996842A (en) * | 2015-08-20 | 2015-10-28 | 兴安县森澳养殖有限公司 | Piglet feed additive |
CN104996840A (en) * | 2015-08-20 | 2015-10-28 | 兴安县森澳养殖有限公司 | Pig starter feed additive for preventing and treating diarrhoea |
CN105010889A (en) * | 2015-08-20 | 2015-11-04 | 兴安县森澳养殖有限公司 | Chinese herbal medicine piglet feed additive |
CN106177834A (en) * | 2016-07-18 | 2016-12-07 | 安徽奥力欣生物科技有限公司 | A kind of Chinese medicine microecological preparation treating Intestinum Sus domestica tract disease and preparation method thereof |
CN106819475A (en) * | 2017-02-09 | 2017-06-13 | 合肥隆扬农业科技有限公司 | A kind of feed of prevention of diarrhea in piglets |
CN110354217A (en) * | 2019-06-28 | 2019-10-22 | 江苏合纵思远生物科技有限公司 | A kind of Chinese medical extract that treating grice diarrhoea and preparation method |
CN110892951A (en) * | 2019-11-22 | 2020-03-20 | 中国农业大学 | Method for preparing piglet anti-diarrhea feed by using anaerobic enzymolysis composite traditional Chinese medicine residues |
CN112023018A (en) * | 2020-10-23 | 2020-12-04 | 广西壮族自治区兽医研究所 | A kind of traditional Chinese medicine composition for preventing and treating livestock diarrhea and its preparation method and application |
CN113615773A (en) * | 2017-04-14 | 2021-11-09 | 浙江艾杰斯生物科技有限公司 | Feed additive containing lysozyme and traditional Chinese medicine extract |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102524579A (en) * | 2012-01-12 | 2012-07-04 | 福建省莆田市优利可农牧发展有限公司 | Traditional Chinese medicine additive for pig feed and preparation method and application for traditional Chinese medicine additive |
CN103202909A (en) * | 2013-04-01 | 2013-07-17 | 陈鹏举 | Traditional Chinese medicine feed additive for preventing and curing diarrhea of livestock and poultry as well as fur-bearing animals |
CN103860714A (en) * | 2013-05-07 | 2014-06-18 | 武汉市畜牧兽医科学研究所 | Compound traditional Chinese medicine extract for preventing and treating livestock diarrhea syndrome and application thereof |
-
2015
- 2015-06-11 CN CN201510317143.XA patent/CN104840934A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102524579A (en) * | 2012-01-12 | 2012-07-04 | 福建省莆田市优利可农牧发展有限公司 | Traditional Chinese medicine additive for pig feed and preparation method and application for traditional Chinese medicine additive |
CN103202909A (en) * | 2013-04-01 | 2013-07-17 | 陈鹏举 | Traditional Chinese medicine feed additive for preventing and curing diarrhea of livestock and poultry as well as fur-bearing animals |
CN103860714A (en) * | 2013-05-07 | 2014-06-18 | 武汉市畜牧兽医科学研究所 | Compound traditional Chinese medicine extract for preventing and treating livestock diarrhea syndrome and application thereof |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104996842A (en) * | 2015-08-20 | 2015-10-28 | 兴安县森澳养殖有限公司 | Piglet feed additive |
CN104996840A (en) * | 2015-08-20 | 2015-10-28 | 兴安县森澳养殖有限公司 | Pig starter feed additive for preventing and treating diarrhoea |
CN105010889A (en) * | 2015-08-20 | 2015-11-04 | 兴安县森澳养殖有限公司 | Chinese herbal medicine piglet feed additive |
CN106177834A (en) * | 2016-07-18 | 2016-12-07 | 安徽奥力欣生物科技有限公司 | A kind of Chinese medicine microecological preparation treating Intestinum Sus domestica tract disease and preparation method thereof |
CN106819475A (en) * | 2017-02-09 | 2017-06-13 | 合肥隆扬农业科技有限公司 | A kind of feed of prevention of diarrhea in piglets |
CN113615773A (en) * | 2017-04-14 | 2021-11-09 | 浙江艾杰斯生物科技有限公司 | Feed additive containing lysozyme and traditional Chinese medicine extract |
CN113615773B (en) * | 2017-04-14 | 2023-07-25 | 浙江艾杰斯生物科技有限公司 | A kind of feed additive containing lysozyme and traditional Chinese medicine extract |
CN110354217A (en) * | 2019-06-28 | 2019-10-22 | 江苏合纵思远生物科技有限公司 | A kind of Chinese medical extract that treating grice diarrhoea and preparation method |
CN110892951A (en) * | 2019-11-22 | 2020-03-20 | 中国农业大学 | Method for preparing piglet anti-diarrhea feed by using anaerobic enzymolysis composite traditional Chinese medicine residues |
CN112023018A (en) * | 2020-10-23 | 2020-12-04 | 广西壮族自治区兽医研究所 | A kind of traditional Chinese medicine composition for preventing and treating livestock diarrhea and its preparation method and application |
CN112023018B (en) * | 2020-10-23 | 2022-04-05 | 广西壮族自治区兽医研究所 | A kind of traditional Chinese medicine composition for preventing and treating livestock diarrhea and its preparation method and application |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104840934A (en) | Traditional Chinese medicine composition for preventing and treating piglet diarrhea and preparation method of traditional Chinese medicine composition | |
CN103271230B (en) | Traditional Chinese medicine feed for promoting pig growth and preparation method as well as application thereof | |
CN118434431A (en) | Traditional Chinese medicine composition and preparation method and application thereof | |
CN103250878B (en) | Traditional Chinese medicine feed for treating swine plague, as well as preparation method and appliction thereof | |
KR20160119999A (en) | Gongjindan based on dongibogam and method of manufacturing the same | |
CN104068177A (en) | Health-care life-lengthening natural plant tea | |
CN103301267A (en) | Traditional Chinese medicine composition for treating hypertension and/or atherosclerosis and application thereof | |
CN114404517A (en) | Composition for gout and reducing uric acid and application and preparation method thereof | |
CN115969909B (en) | Traditional Chinese medicine composition and fermented traditional Chinese medicine preparation for improving sub-health of sow as well as preparation method and application of traditional Chinese medicine composition and fermented traditional Chinese medicine preparation | |
KR102217732B1 (en) | Composition for preventing and improving the development of premature pseudo-breast | |
CN105232959B (en) | A Chinese medicinal composition | |
CN107823293A (en) | Treat Yao nationality medicine external pulvis of canker sore and preparation method thereof | |
KR20210157522A (en) | Composition for preventing, ameliorating or treating diabetic nepropathy comprising bangpungtongseongsan extract as effective component | |
CN105327147A (en) | Medicine composition for treating swine enzootic pneumonia and preparation method thereof | |
CN104905032A (en) | Feed additive for preventing and treating hepatitis of truogx sinensis | |
CN111084878A (en) | Biological medicine and medical total nutrient food for lung and respiratory system diseases and preparation method thereof | |
CN112494614A (en) | Chinese medicinal formula for preventing and treating cancer by using combination of pawpaw and various medicines | |
CN104984141A (en) | Prescription for treating constipation and preparation method thereof | |
CN106310226B (en) | Traditional Chinese medicine compound preparation for preventing and treating piglet diarrhea and preparation method thereof | |
CN104971294A (en) | Traditional Chinese medicine composition for preventing and treating cattle pneumonia and orally-taken preparation | |
CN104840773A (en) | Traditional Chinese medicine composition for treating vertebral artery type cervical spondylopathy and method for preparing same | |
CN110663954A (en) | Health food for eliminating dampness and expelling toxin and preparation method thereof | |
CN116942745B (en) | Traditional Chinese medicine composition for treating salpingitis of laying hens and preparation method thereof | |
CN111920898B (en) | Antiviral prescription and preparation method thereof | |
CN107519261A (en) | A kind of Chinese medicine composition for treating leukaemia and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150819 |
|
RJ01 | Rejection of invention patent application after publication |